Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-23

Clinical Trial Update: Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial investigating whether stopping magnesium sulfate after delivery is safe and effective for women with severe preeclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Cairo University | Conditions: Preeclampsia Severe | Phase 4 | Status: UNKNOWN